Full name
DR PORADA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
47.91.Z - Intermediary retail sale, non-specialized
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,2 | 0 | 1,3 | -∞ |
EBITDA | 1,2 | 0 | 1,3 | -∞ |
Short time liabilities | 0,8 | 1 | 1,2 | 21,1 |
Equity capital | 1,7 | 1,9 | 1,7 | -14,8 |
Operating profit (EBIT) | 1,2 | 0 | 1,3 | -∞ |
Assets | 2,6 | 3 | 2,9 | -3,6 |
Net profit (loss) | 1 | 0 | 1 | -∞ |
Cash | 0,8 | 1,3 | 0,9 | -31,4 |
Liabilities and provisions for liabilities | 0,9 | 1,1 | 1,3 | 16,2 |
Net income from sale | 12 | 0 | 13,8 | -∞ |
Working assets | 2,5 | 2,9 | 2,9 | -2,6 |
Depreciation | 0 | 0 | 0,1 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 56,4 | 0 | 62,4 | 62,4 |
Equity capital to total assets | 65 | 63,9 | 56,5 | -7,4 |
Gross profit margin | 9,9 | 9,3 | -0,6 | |
EBITDA Margin | 10,2 | 9,6 | -0,6 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 25 | 2 147 483 648 | 31 | -2 147 483 617 |
Current financial liquidity indicator | 2.741718292236328 | 2.6798434257507324 | 2.2456815242767334 | -0,5 |
Net dept to EBITDA | -0.6372663974761963 | -0.6564638018608093 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane